Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ May 19, 2020
Roller Compaction scale-up made simple: an approximate analytical solution to Johanson's rolling theory
Read more
Scientific Article
/ Apr 03, 2020
Chalcones: Retrospective synthetic approaches and mechanistic aspects of a privileged scaffold
Read more
Scientific Article